Abnormal Vasoconstrictor Responses to Angiotensin II and Noradrenaline in Isolated Small Arteries From Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Authors:
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (4) , 853-858
Abstract
Background and Purpose— Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by ultrastructural abnormalities in small cerebral and systemic vessels. We assessed vasomotor function in systemic small arteries in CADASIL. Methods— We studied 10 CADASIL patients and 10 control subjects. Resistance arteries isolated from gluteal biopsies were mounted on small-vessel myographs, and concentration responses were determined for vasoconstrictors (noradrenaline, angiotensin II, and endothelin-I) and vasodilators (acetylcholine, bradykinin, spermine-NONOate, and nifedipine). Maximum data are shown as percent potassium contraction. Results— There was reduced potency for noradrenaline in CADASIL (CADASIL [38 arteries]: EC 50 , 240 nmol/L; control subjects [27 arteries]: EC 50 , 100 nmol/L; 2-way analysis of variance, F=9.76, P =0.002). Maximum response to angiotensin II was greater in CADASIL (120±8% versus 97±5% in control subjects; F=4.28, P =0.043). Tachyphylaxis to angiotensin II occurred in all control subjects studied but in only 3 of 9 CADASIL subjects ( P =0.011, Fisher’s exact test). Vasodilation was similar in CADASIL patients compared with control subjects for endothelium-dependent dilators (acetylcholine and bradykinin) and endothelium-independent dilators (spermine-NONOate and nifedipine). Conclusions— These results suggest a selective systemic microvascular vasoconstrictor abnormality in CADASIL in noradrenaline and angiotensin II pathways that is not explained by vasodilator impairment in endothelium or vascular smooth muscle. This could have important implications for prophylaxis and treatment of CADASIL.Keywords
This publication has 18 references indexed in Scilit:
- Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial FunctionCirculation Research, 2003
- Determinants of Notch-3 Receptor Expression and Signaling in Vascular Smooth Muscle CellsCirculation Research, 2002
- Coordinate Notch3-Hairy-related Transcription Factor Pathway Regulation in Response to Arterial InjuryJournal of Biological Chemistry, 2002
- Endothelium-dependent desensitization to angiotensin II in rabbit aorta: the mechanisms involvedCanadian Journal of Physiology and Pharmacology, 2001
- Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 ratKidney International, 2000
- CADASIL: Notch signaling defect or protein accumulation problem?Journal of Clinical Investigation, 2000
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996
- World Medical Association Declaration of HelsinkiLaw, Medicine and Health Care, 1991
- Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in manNature, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983